Researchers investigate defects in the DJ1 gene in Parkinson’s
2 March 2016 | By Victoria White
Researchers looked at the metabolism of neurons lacking DJ1 and discovered that two key metabolic pathways are affected...
List view / Grid view
News
Cypralis appoints a new Chief Scientific Officer
2 March 2016 | By Victoria White
Cypralis, a company focussed on the discovery of novel therapeutics based on modulation of PPIases, has appointed Dr Michael Peel as Chief Scientific Officer...
Celyad gets patent for TCR-deficient CAR T-cell method
2 March 2016 | By Victoria White
The US Patent 9,273,283 is the second patent of Celyad allogeneic intellectual property portfolio that is awarded by the USPTO...
UCI study points to new treatments to limit effects of Alzheimer’s
1 March 2016 | By Victoria White
Using pexidartinib to flush away the inflammatory cells produced in reaction to beta-amyloid plaques, scientists restored memory function in test mice...
FDA makes $2 million available to fund natural history studies in rare diseases
1 March 2016 | By Victoria White
The aim is to collect data on how specific rare diseases progress in individuals over time so that knowledge can inform and support product development and approval...
AChE peptide key driver for neuronal death in Alzheimer’s
1 March 2016 | By Victoria White
The AChE peptide has been shown to drive production of both amyloid and hyperphosphorylated tau in Alzheimer's disease...
Electron microscopy details infection mechanisms of coronaviruses
29 February 2016 | By Victoria White
High-resolution cryo-electron microscopy and supercomputing have now made it possible to analyse in detail the infection mechanisms of coronaviruses...
Lamellar teams up with ECFP to create novel Lamellasomes
29 February 2016 | By Victoria White
Through the partnership, Lamellar hopes to gain a more detailed understanding of the biophysical properties of Lamellasomes and hence their mode of action...
PeptiMimesis to develop next generation therapeutic peptides
29 February 2016 | By Victoria White
PeptiMimesis is a new biotech startup developing a novel class of therapeutic peptides using a breakthrough technology...
Tarantula toxin, ProTx-II, shows promise as a painkiller
29 February 2016 | By Victoria White
ProTx-II, a peptide toxin found within the venom of the Peruvian green velvet tarantula, has a high potency and selectivity to inhibit the pain sensation receptor...
Regen completes preclinical experimentation for its NR2F6 checkpoint inhibitor
26 February 2016 | By Victoria White
Regen has recently filed two patent applications covering the molecular pathways activated by NR2F6 silencing...
Targeted substance selectively blocks Alzheimer’s disease enzyme
26 February 2016 | By Victoria White
Researchers have developed a targeted substance that blocks the pathogenic function of an enzyme that is partly responsible for Alzheimer’s disease without affecting its other vital functions...
Single antibody protects non-human primates from Ebola virus
26 February 2016 | By Victoria White
A single monoclonal antibody isolated from a human survivor of Ebola virus completely protected monkeys from lethal infection with the virus...
Adaptive therapy inhibits chemo-resistance in study
25 February 2016 | By Victoria White
Adaptive therapy is based on evolutionary principals and aims to keep resistant cells in check by maintaining a population of chemo-sensitive cells...
Gilead announces preclinical results for TLR7 agonist GS-9620
25 February 2016 | By Victoria White
Data from the preclinical study support continued investigation of GS-9620 as part of an HIV eradication strategy…